Submitted by Anonymous (not verified) on 27 March 2025 - 16:40
Human medicines European public assessment report (EPAR): Laventair Ellipta (previously Laventair), umeclidinium bromide,vilanterol, Date of authorisation: 08/05/2014, Revision: 20, Status: Authorised
Source: